Summit Securities Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-802	Closed	-$19K	–	379
2013 Q2	$19K	Buy	+802	New	+$19K	0.01%	219